期刊文献+

脐血干细胞的生物学特性及其应用 被引量:6

Cord Blood Stem Cell:Basic Biology and Transplantation
下载PDF
导出
摘要 脐血干细胞为干细胞移植提供了新的选择,与外周血及骨髓干细胞相比,脐血干细胞移植后的低急慢性移植物抗宿主病(GVHD)发病率、低移植相关死亡率(TRM)及疾病复发率具有明显优势,易获得性及免疫耐受等特性使其越来越受到人们的关注,并吸引人们不断进行深入的研究。归纳总结脐血干细胞与胚胎干细胞、骨髓干细胞及外周血干细胞的优缺点,概括脐血干细胞移植在临床及再生医学中日益广泛的应用,重点阐述脐血干细胞治疗血液系统疾病的优势及面临的问题和解决方案。脐血干细胞移植的巨大优势为干细胞移植开创了新的篇章。 In recent years,cord blood stem cell(CB-SCS) has emerged as an alternative source of stem cell transplantation.CB-SCS transplantation was associated with a significantly lower incidence of graft-versus-host disease(GVHD),lower transplant related mortality(TRM) and disease recurrence,compared with bone marrow and peripheral blood stem cells.This review report an itemized classification of CB-SCs populations,which is important to better understand which tissues can be replaced using CB-SCs and how the generation of induced pluripotent stem cells from CB-SCs is changing the field.Furthermore,we also review the transplantation of CB-SCs in the clinical and regenerative medicine for a variety of malignant and non-malignant diseases,especially for hematological diseases.The great advantage of umbilical cord blood stem cell create a new chapter for stem cell transplantation.
出处 《国际妇产科学杂志》 CAS 2011年第2期89-92,共4页 Journal of International Obstetrics and Gynecology
基金 上海市科委基金(08ZR1405300)
关键词 脐血干细胞移植 血液病 再生医学 Cord blood stem cell transplantation Hematologic diseases Regenerative medicine
  • 相关文献

参考文献38

  • 1Pittenger MF, Mackay AM, Beck SC,et al. MuItilineage potential of aduh human mesenchymal stem cells [J]. Science,1999,284 (5411) : 143.147.
  • 2Tyndall A, Walker UA, Cope A, et al.Immunomodulatory properties of mesenchymal stem ceils: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London,UK, 31 October 2005 [J]. Arthritis Res Ther,2007,9( 1 ) : 301.
  • 3McGuckin CP,Forraz N. Potential for access to embryoniclike cells from human umbilical cord blood [J]. Cell Prolif,2008,41 (Suppl 1 ) :31-40.
  • 4Weiss ML,Troyer DL.Stem cells in the umbilical cord [J]. StemCell ltev ,2006,2 (2) :155-162.
  • 5van Rood JJ,Stevens CE, Smits J, et al. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant out- come in hematological malignancies [J]. Proc Natl Acad Sci U S A, 2009,106 (47) : 19952-19957.
  • 6Kogler G,Sensken S,Airey JA,et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentia- tion potential [J]. J Exp Med ,2004,200(2) : 123-135.
  • 7Senseb6 L, Bourin P. Mesenchymal stem cells for therapeutic pur- poses[J]. Transplantation ,2009,87 (Suppl) :S49-S53.
  • 8Kita K, Gauglitz GG , Phan TI', et al. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane [J ]. Stem Cells Dev, 2010,19 (4) :491-502.
  • 9Liedtke S,Buchheiser A, Bosch J,et al, The HOX Code as a "bio- logical fingerprint" to distinguish functionally distinct stem cell populations derived from cord blood [J]. Stem Cell Res,2010,5 ( 1 ) :40-50.
  • 10Shaheen M, Broxmeyer HE. The humoral regulation of hematopoiesis [M]//Hoffman R, Furie B, Benz EJ, et al. Hematolo- gy: basic principles and practice. 5th ed. Philadelphia, PA :Elsevier Churchill Livingston, 2009: 253-275.

二级参考文献14

共引文献13

同被引文献85

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部